Integrated care

Flagship cancer fund underspent amid uncertainty over its future

By 2018-01-31T06:00:00

drugs

NHS England’s flagship cancer drugs fund had spent just over a quarter of its budget halfway through this financial year, amid questions over its long term future.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here